Acelyrin Inc
(SLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 73,890 | 218,097 | 267,110 | 102,242 |
| Marketable Securities | 373,990 | 503,229 | 47,510 | N/A |
| TOTAL | $480,987 | $736,638 | $316,064 | $102,304 |
| Non-Current Assets | ||||
| PPE Net | 1,635 | 2,179 | N/A | N/A |
| Other Non-Current Assets | 8,519 | 3,873 | 3,859 | 0 |
| TOTAL | $10,154 | $6,052 | $3,859 | $N/A |
| Total Assets | $491,141 | $742,690 | $319,923 | $102,304 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 4,888 | 41,920 | 5,947 | 1,133 |
| Accrued Expenses | 11,042 | 35,436 | 5,717 | 9,697 |
| Other current liabilities | 1,351 | 970 | N/A | N/A |
| TOTAL | $26,578 | $85,159 | $15,901 | $11,740 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 6,270 | 1,194 | 10,291 | 0 |
| TOTAL | $6,270 | $1,194 | $10,291 | $N/A |
| Total Liabilities | $32,848 | $86,353 | $26,192 | $11,740 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 100,710 | 98,365 | N/A | N/A |
| Common Shares | 1 | 1 | N/A | N/A |
| Retained earnings | -736,945 | -488,719 | -107,078 | -42,306 |
| Other shareholders' equity | -6 | 162 | 396,507 | 132,620 |
| TOTAL | $458,293 | $656,337 | $293,731 | $90,564 |
| Total Liabilities And Equity | $491,141 | $742,690 | $319,923 | $102,304 |